Cargando…
Cyclic adenosine monophosphate-elevating agents inhibit amyloid-beta internalization and neurotoxicity: their action in Alzheimer’s disease prevention
Autores principales: | Gopalakrishna, Rayudu, Oh, Andrew, Bhat, Narayan R., Mack, William J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358646/ https://www.ncbi.nlm.nih.gov/pubmed/37449618 http://dx.doi.org/10.4103/1673-5374.373664 |
Ejemplares similares
-
Nogo-A receptor internalization by cyclic adenosine monophosphate in overcoming axonal growth inhibitors after stroke
por: Gopalakrishna, Rayudu, et al.
Publicado: (2021) -
Cell signaling associated with internalization of 67 kDa laminin receptor (67LR) by soluble laminin and its implication for protection against neurodegenerative diseases
por: Gopalakrishna, Rayudu, et al.
Publicado: (2019) -
Osthole-Mediated Inhibition of Neurotoxicity Induced by Ropivacaine via Amplification of the Cyclic Adenosine Monophosphate Signaling Pathway
por: Wang, WeiBing, et al.
Publicado: (2022) -
Counteraction of Nogo-A and axonal growth inhibitors by green tea polyphenols and other natural products
por: Fan, Tiffany K., et al.
Publicado: (2016) -
The cyclic adenosine monophosphate elevating medicine, forskolin, reduces neointimal formation and atherogenesis in mice
por: Hao, Huifeng, et al.
Publicado: (2020)